
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.(AVXL)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
avxl · 股价预测 · 13 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$11.00
Consensus
$11.00
+326.7% upside
Low
$11.00
Median: $11 · Last Close: $2.58
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
在 ±3 天财报窗口期内暂停短期预测,以避免不可靠信号。
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -26.2% |
| 2028 | $2 | -35.9% |
| 2029 | $2 | -40.1% |
| 2030 | $1 | -42.0% |
| 2031 | — | -43.0% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AVXL · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-31 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-26 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-03-23 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-09 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-01-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-12-19 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-15 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Anavex Life Sciences Corp. (AVXL) stock. Of the recent 73 rating actions, 0 were upgrades and 2 were downgrades. 13 analysts currently cover AVXL.
分析师推荐趋势
AVXL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$776M
↑ 122.6% YoY
Revenue Next Year
$1.2B
↑ 55.9% YoY
EPS This Year
$-0.33
EPS Next Year
$-0.55
↑ 66.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast AVXL EPS of $-0.33 for the current fiscal year, based on estimates from 1 analysts. The AVXL revenue forecast is $776M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AVXL 股价预测由两类独立数据源支撑:来自 13 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。AVXL 的共识目标价为 $11.00(+326.7% 上行空间),分析师共识为 Buy。
AVXL 对 2027 年的股价预测均值为 $2。 AVXL 对 2030 年的预测区间为 $1–$2。
Anavex Life Sciences Corp. 在 NASDAQ 上市,代码 AVXL。AVXL 在 2027 年的整体展望偏积极,在覆盖分析师中约 85% 对应 Buy 共识。
常见问题
AVXL 预测 · 8 个问题根据 13 位华尔街分析师,AVXL 的 12 个月平均目标价为 $11.00,最高 $11.00、最低 $11.00。若有图表,中位目标价可在上方查看。相对当前价 $2.58,隐含约 +326.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.